. In evaluation II, AFTA and FTA-ABS tests were performed on 789 sera from clinically defined donor groups to study the agreement between the tests and the agreement of each test with clinical diagnosis; in addition, the reproducibility of both automated and manual procedures was determined. In evaluation III, 628 serum specimens submitted from ongoing clincal studies were tested with the automated test, using the improved instrument and technique, and with the manual test to study agreement between the two procedures and agreement of each procedure with clinical diagnosis.
MATERIALS AND METHODS Equipment. The SeroMatic System for the AFTA test has been described in detail elsewhere (1) . In brief, the system consists of a slide processor, reagent reservoirs, serum-sorbent blocks, and microscope attachments.
The slide processor is an electropneumatically controlled device with: (i) a circular rotating Specimens were obtained from patients admitted to vernereal disease clinics, general outpatient clinics and hospitals, and those on whom routine blood tests were performed. The diagnosis of syphilis or nonsyphilis was made on the correlation of available historical, clinical, and serological data.
Specimens were processed in groups containing sera randomly selected from the various clinical categories. The serologist performing the tests did so without prior knowledge of the clinical category of the specimens.
Reproducibility study. In evaluation II, to determine test reproducibility within a laboratory, one serum from a patient diagnosed as late latent syphilis was divided into 120 samples; 60 samples were tested with each procedure. This serum was nonreactive in the VDRL slide test and reactive in prior TPI and FTA-ABS tests.
Test procedures. The FTA-ABS test was performed according to the published technique (9) , and the AFTA test was performed according to the provisional technique, dated May 1969 (10) . Manual operations performed in the AFTA test included processing of sera; measuring serum and sorbent into the numbered cavities of blocks; loading the intrument with the blocks, prenumbered antigen slides, and other reagents; and reading the processed test slides. All other steps of the indirect fluorescent-antibody test were performed automatically by the slide processor.
RESULTS
The reactivity rates of the FTA-ABS and AFTA tests with clinical categories are shown in Table 1 . Reactivity of the combined syphilis sera was 92.5% with the FTA-ABS test and 90.6% with the AFTA test in evaluation II and 86.5% FTA-ABS and 83.5% AFTA in evaluation III. Twothirds of the syphilis specimens included in evaluation III were obtained from patients adequately treated for early syphilis. Fifteen of these sera were nonreactive and 15 were borderline. This accounts for the apparent reduction in sensitivity provisional technique used in these evaluations. During these studies, personnel from AerojetGeneral made several adjustments and modifications on the slide processor. These included redesigning the incubators to maintain a constant temperature and to decrease the reagents drying on the slides, improving the mechanism for delivering serum-sorbent mixture to the slides so that the entire specimen is applied to the correct slide and splatter of specimens to the adjacent slides is eliminated, and redesigning the serumsorbent blocks for more efficient cleaning and prevention of specimen leakage. During evaluation II, the instrument was monitored continuously, and minor malfunctions which occurred were corrected manually. Because of the improved operation of the instrument, monitoring was done only on a spot-check basis in evaluation III.
A Increasing usage and reliance upon the FTA-ABS test for the prompt resolution of problem cases, as well as on all reactive specimens, by public health and clinical laboratories suggest that the successful automation of this procedure is timely and significant and could be an effective tool in the serodiagnosis of syphilis.
